Publications by authors named "Rafia Chaudhry"

Background and objective Hemodialysis patients often have lower serum low-density lipoprotein (LDL) and total cholesterol concentrations compared to the general population. It is unclear if this is due to a persistent decline in the values due to kidney disease or if the hemodialysis itself is contributing to the lower values. It is often assumed that malnutrition and anorexia are the main causes of the low lipid concentration in hemodialysis patients.

View Article and Find Full Text PDF

The COVID-19 pandemic has had a profound impact on the nation's health care system, including on graduate medical education (GME) training programs. Traditionally, residency and fellowship training program applications involve in-person interviews conducted on-site, with only a minority of programs offering interviews remotely via a virtual platform. However, in light of the COVID-19 pandemic, it is anticipated that most interviews will be conducted virtually for the 2021 application cycle and possibly beyond.

View Article and Find Full Text PDF
Article Synopsis
  • Atherosclerotic cardiovascular disease (ASCVD) is a major health problem for people with chronic kidney disease (CKD) and can lead to serious issues or even death.
  • CKD makes patients more likely to need stronger treatments to lower bad cholesterol levels, but there is debate about how effective these treatments are, especially for those on dialysis.
  • Some studies suggest that using statins can help reduce heart events for CKD patients not on dialysis, but new cholesterol-lowering drugs haven't been widely tested in these patients yet.
View Article and Find Full Text PDF

Peritoneal Dialysis (PD) patients are at increased risk of peritonitis following elective colonoscopy and other potentially invasive dental or gynecological procedures. The increased risk of iatrogenic peritonitis is attributed to procedure-related factors such as instrumentation, biopsies, tissue injury, and peri-procedural bacterial contamination. Also contributory are patient-related factors such as the effect of the immunocompromised status of end-stage renal disease and the presence of intraperitoneal dialysate on the disruption of natural host defense mechanisms.

View Article and Find Full Text PDF

Background And Objectives: Anti-neutrophil cytoplasmic autoantibodies (ANCA) associated vasculitis is a small vessel vasculitis with insufficient epidemiologic estimates in the United States. We aimed to determine demographic and clinical features of ANCA associated vasculitis patients presenting to a large tertiary care referral center in Upstate New York. Design, setting, participants, and measurements: A retrospective analysis of cases with pauci-immune GN on renal biopsy and clinical diagnosis of ANCA vasculitis presenting over 11 years was conducted.

View Article and Find Full Text PDF
Article Synopsis
  • - Atherosclerotic cardiovascular disease (ASCVD) significantly impacts patients with chronic kidney disease (CKD), especially those with reduced kidney function, yet there's limited trial data to inform doctors on how to manage this population effectively.
  • - A survey was conducted among 450 nephrology and cardiology providers, yielding 113 responses, where over 90% recognized CVD's serious effects on CKD patients, but only 5% would screen asymptomatic patients with advanced CKD for ASCVD.
  • - The study highlights a lack of agreement on treating ASCVD in advanced CKD and emphasizes the need for future clinical trials, although the findings are constrained by a small sample size and low response rates.
View Article and Find Full Text PDF

Vascular endothelial dysfunction and increased arterial stiffness contribute to increased cardiovascular risk in patients with CKD who exhibit chronic systemic inflammation. Because chronic inflammation contributes to vascular dysfunction, blocking inflammation may reduce cardiovascular risk in patients with CKD. In a two-site, double-blind trial, we randomized 42 adult patients with stage 3-4 CKD who were already receiving optimal background therapy to receive either IL-1 trap rilonacept or placebo for 12 weeks.

View Article and Find Full Text PDF

Peritoneal dialysis (PD) is a widely accepted and increasingly popular form of dialysis. The invention and technological advancement of the PD cycler further makes PD a convenient option. Prescription-specific parameters are entered into the cycler, which then automatically carries out the steps involved in continuous cycling PD.

View Article and Find Full Text PDF

Introduction: Studies have shown a high prevalence of psychiatric illnesses among patients in primary health care settings. Family physicians have a fundamental role in managing psychiatric illness with psychopharmacological medications. Providing information about the disease, its management and the potential adverse effects of the medications is an important part of the management of mental illnesses.

View Article and Find Full Text PDF